Navigation Links
Nuvo Announces 2009 second quarter financial results
Date:8/7/2009

MISSISSAUGA, ON, Aug. 7 /PRNewswire-FirstCall/ - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, today announced its financial and operational results for the quarter ended June 30, 2009.

    Recent Corporate Developments:

    -   Received correspondence from U.S. Food and Drug Administration
        ("FDA") on August 4, 2009 advising that it was extending the
        Prescription Drug User Fee Act date ("PDUFA date") for Pennsaid
        approval to November 4, 2009;

    -   Entered into a license and development agreement with Mallinckrodt
        Inc., a subsidiary of Covidien (NYSE: COV), a leading global provider
        of healthcare products, granting it exclusive rights to market and
        sell Pennsaid(R), and its follow-on product, Pennsaid Plus(R), in the
        United States;

    -   Pennsaid Phase 3 study results were published in June 2009 edition of
        PAIN, the world's leading publication on pain research and
        treatments, and the official journal of the International Association
        for the Study of Pain; and,

    -   Nuvo had $26.3 million in cash and cash equivalents at June 30, 2009
        following receipt of the US$10 million upfront payment received from
        Covidien respecting its U.S. license of Pennsaid and Pennsaid Plus.
        Subsequent to the quarter end, Nuvo received additional proceeds of
        $5.7 million from the exercise of warrants that otherwise would have
        expired on July 13, 2009.

"While a decision from the FDA on our submission for Pennsaid has been delayed, we remain optimistic that Pennsaid will ultimately be approved for marketing in the United
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2. NATB Announces Partnership With Ronald McDonald House Charities(R)
3. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
6. AMN Healthcare Announces Second Quarter 2009 Results
7. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
8. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
9. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
10. Feline Pine Announces National Take Your Cat to the Vet Day August 22
11. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Asbury Park, NJ (PRWEB) , ... August 03, ... ... is pleased to announce the development of it’s new program “Designing Secure Healthcare ... provide software architects, engineers and technology leaders from healthcare organizations with access to ...
(Date:8/3/2015)... ... , ... A July 13 article from The Daily Mail titled "Jab ... That Can Last 'For Five Weeks'" discusses the use of stem cells to ... that harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal ...
(Date:8/3/2015)... Ramon, CA (PRWEB) , ... August 03, 2015 ... ... leading global insurance brokerage firm, announced today that Joe Williams has joined its ... development, sales, and delivering HUB's differentiated service model to his clients. Mr. Williams ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, an online ... the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, ... opportunity the AHDI conference provides us to interact with those in the healthcare ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
... research by University of Leeds scientists (UK) discovers that a ... bodies to make their own medicine// and there will soon ... Simon Carding of Leeds' Faculty of Biological Sciences has adapted ... a treatment for Inflammatory Bowel Disease (IBD). Bacteria and viruses ...
... dozen people have taken ill and have been hospitalized in ... ‘ baseless’ by spokesman Xiong Yuanda of the Health Bureau ... infectious ‘unknown’ disease, doing the rounds in the city, as ... bureau has sought to dispel reports carried by a famous ...
... scientist, Simon Carding, has genetically altered or designed bacteria ... , The bacterium ; Bacterium ovatus, one of ... to produce human growth factors called cytokines. These were ... damaged by the disease, hence reducing the inflammation. ...
... food allergies are the reasons for many common ailments among ... British residents who have encountered health related issues due to ... it was found out that food intolerance is the root ... intolerance is one of the common forms of food intolerance. ...
... care homes are not being properly attended to in London. As ... in hunger// for most of the time. This was disclosed by ... older people’ campaign Mr. Lewis said that issues during the meal ... is kept far from an old person and nobody is around ...
... an Indian Army officer has become the first person to ... Service//. ,Major S.K. Singh of the Regiment of Artillery ... was declared brain dead at the premier Army Hospital (Research ... statement said. ,The elder Singh was suffering ...
Cached Medicine News:Health News:A Spoonful Of Sugar to 'Switch' the Bacteria on and Off 2Health News:‘Sweet Revenge’ on Inflammatory Bowel Disea 2
(Date:8/2/2015)... THE WOODLANDS, Texas , Aug. 3, 2015 ... today announced that the pivotal TELESTAR Phase 3 ... benefit of oral telotristat etiprate in treating cancer ... controlled by the current standard of care. Telotristat ... on Nobel Prize-winning technology, and is the company,s ...
(Date:7/31/2015)... More than 1,500 substance abuse prevention and ... Indianapolis Aug. 2-6 for Community ... Institute . The week-long training, held at the JW ... our nation,s biggest public health challenges – youth drug ... a one-of-a-kind intensive training opportunity, offering more than 70 ...
(Date:7/31/2015)...  Boston Children,s Hospital physicians report the first ... their anatomy before undergoing high-risk brain procedures. The ... the brain,s blood vessels) that posed special treatment ... Journal of Neurosurgery: Pediatrics , the physicians ... resins to create custom, high-fidelity models of the ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 23D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4
... , SILVER SPRING, Md. , May 6 The Food and Drug Administration (FDA) ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ... Certain external defibrillators that were recalled because they may malfunction during ... , , ...
... Academy Award, Emmy Award, and Golden Globe Award-nominated actress Lorraine ... a 30-minute public affairs television program that tells the compelling and inspirational stories ... stations nationwide. , , , ... for her gritty portrayal of mob wife Karen Hill in the ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: April 2010 2FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: April 2010 3'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 2'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 3'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 4'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 5'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 6'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 7'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 8'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 9'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 10'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 11'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 12'Sharing Miracles' Television Program to Feature Academy Award Nominee Lorraine Bracco 13
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
... of a 42" long suture inserted into a ... one end and scored on the other. The ... to a ST-3 needle. The opposite end of ... of the plastic tube. The scored end acts ...
... long ligature inserted into a plastic tube. The plastic ... the other. The suture protrudes from the narrow end ... knot which becomes secure after the device is activated. ... the scored end of the plastic tube. The scored ...
... consists of 18'' long ligature inserted into a plastic ... and scored on the other. The suture protrudes from ... loop with a knot which becomes secure after the ... is fastened to the scored end of the plastic ...
Medicine Products: